Wetherby Asset Management Inc Pfizer Inc Transaction History

Wetherby Asset Management Inc

$2.13 Billion
Q3 2024

A detailed history of Wetherby Asset Management Inc transactions in Pfizer Inc stock. As of the latest transaction made, Wetherby Asset Management Inc holds 118,291 shares of PFE stock, worth $3.18 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

118,291

Previous 123,741 4.4%

Holding current value

$3.18 Million

Previous $3.46 Million 1.13%

% of portfolio

0.16%

Previous 0.17%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$27.7 - $31.39 $150,965 - $171,075	-5,450 Reduced 4.4%	118,291 $3.42 Million
Q2 2024 Aug 14, 2024	BUY	$25.26 - $29.6 $214,280 - $251,096	8,483 Added 7.36%	123,741 $3.46 Million
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $526,887 - $605,035	-20,351 Reduced 15.01%	115,258 $3.2 Million
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $204,545 - $265,682	-7,828 Reduced 5.46%	135,609 $3.9 Million
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $389,091 - $454,808	-12,125 Reduced 7.79%	143,437 $4.76 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $328,114 - $379,620	9,084 Added 6.2%	155,562 $5.71 Million
Q1 2023 May 12, 2023	SELL	$39.39 - $51.28 $328,315 - $427,418	-8,335 Reduced 5.38%	146,478 $5.98 Million
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $299,765 - $391,310	7,180 Added 4.86%	154,813 $7.94 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $51,593 - $62,982	-1,179 Reduced 0.79%	147,633 $6.46 Million
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $198,776 - $235,686	4,272 Added 2.96%	148,812 $7.8 Million
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $185,424 - $229,764	4,053 Added 2.88%	144,540 $7.48 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $277,298 - $411,048	6,711 Added 5.02%	140,487 $8.3 Million
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $23,667 - $30,403	603 Added 0.45%	133,776 $5.75 Million
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $276,255 - $312,951	7,693 Added 6.13%	133,173 $5.22 Million
Q1 2021 May 14, 2021	SELL	$33.49 - $37.77 $447,459 - $504,644	-13,361 Reduced 9.62%	125,480 $4.55 Million
Q4 2020 Feb 11, 2021	BUY	$33.47 - $42.56 $450,941 - $573,410	13,473 Added 10.75%	138,841 $5.11 Million
Q3 2020 Dec 16, 2020	SELL	$31.75 - $37.25 $204,470 - $239,890	-6,440 Reduced 4.89%	125,368 $4.6 Million
Q3 2020 Nov 13, 2020	BUY	$31.75 - $37.25 $105,664 - $123,968	3,328 Added 2.59%	131,808 $4.84 Million
Q2 2020 Aug 14, 2020	BUY	$30.12 - $36.54 $253,971 - $308,105	8,432 Added 7.02%	128,480 $4.2 Million
Q1 2020 May 06, 2020	SELL	$27.03 - $38.62 $235,485 - $336,457	-8,712 Reduced 6.77%	120,048 $3.92 Million
Q4 2019 Jan 28, 2020	BUY	$32.92 - $37.36 $15,999 - $18,156	486 Added 0.38%	128,760 $5.04 Million
Q3 2019 Oct 31, 2019	SELL	$32.49 - $42.13 $485,010 - $628,916	-14,928 Reduced 10.42%	128,274 $4.61 Million
Q2 2019 Jul 25, 2019	BUY	$36.98 - $41.52 $172,844 - $194,064	4,674 Added 3.37%	143,202 $6.2 Million
Q1 2019 May 09, 2019	SELL	$37.5 - $41.2 $4,912 - $5,397	-131 Reduced 0.09%	138,528 $5.88 Million
Q4 2018 Jan 30, 2019	BUY	$38.47 - $43.86 $64,937 - $74,035	1,688 Added 1.23%	138,659 $6.05 Million
Q3 2018 Nov 07, 2018	BUY	$34.47 - $41.81 $68,457 - $83,034	1,986 Added 1.47%	136,971 $6.04 Million
Q2 2018 Jul 24, 2018	BUY	$32.98 - $35.16 $23,877 - $25,455	724 Added 0.54%	134,985 $4.9 Million
Q1 2018 May 04, 2018	SELL	$31.91 - $37.02 $28,942 - $33,577	-907 Reduced 0.67%	134,261 $4.76 Million
Q4 2017 Feb 09, 2018	BUY	$33.26 - $35.29 $37,084 - $39,348	1,115 Added 0.83%	135,168 $4.9 Million
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $4.16 Million - $4.58 Million	134,053	134,053 $4.79 Million

Others Institutions Holding PFE

# of Institutions

3,220

Shares Held

3.61B

Call Options Held

77.1M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $151B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wetherby Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wetherby Asset Management Inc with notifications on news.

Account

Wetherby Asset Management Inc Pfizer Inc Transaction History